Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M16,691Revenue $M7,143Net Margin (%)-1.7Z-Score0.8
Enterprise Value $M20,551EPS $-0.1Operating Margin %1.7F-Score8
P/E(ttm))45.1Cash Flow Per Share $1.5Pre-tax Margin (%)-3.1Higher ROA y-yY
Price/Book2.510-y EBITDA Growth Rate %0Quick Ratio1.3Cash flow > EarningsY
Price/Sales2.35-y EBITDA Growth Rate %0Current Ratio1.8Lower Leverage y-yN
Price/Cash Flow3.8y-y EBITDA Growth Rate %1,029ROA % (ttm)-0.7Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-1.9Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M1,323ROI % (ttm)-9.4Gross Margin Increase y-yY

Gurus Latest Trades with BSX

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
BSXVanguard Health Care Fund 2014-06-30 Add0.2%$12.58 - $13.77
($13.01)
$ 12.59-3%Add 16.19%42,743,200
BSXRay Dalio 2014-06-30 Sold Out $12.58 - $13.77
($13.01)
$ 12.59-3%Sold Out0
BSXLeon Cooperman 2014-06-30 Reduce-0.35%$12.58 - $13.77
($13.01)
$ 12.59-3%Reduce -23.25%6,549,479
BSXRay Dalio 2014-03-31 Reduce-0.01%$11.91 - $13.98
($13.08)
$ 12.59-4%Reduce -70.15%36,884
BSXMichael Price 2013-12-31 Add0.47%$11.18 - $12.38
($11.81)
$ 12.597%Add 17.65%2,000,000
BSXRay Dalio 2013-12-31 Buy 0.01%$11.18 - $12.38
($11.81)
$ 12.597%New holding, 123584 sh.123,584
BSXLeon Cooperman 2013-12-31 Reduce-0.88%$11.18 - $12.38
($11.81)
$ 12.597%Reduce -36.64%8,533,099
BSXDodge & Cox 2013-12-31 Reduce-0.18%$11.18 - $12.38
($11.81)
$ 12.597%Reduce -22.34%45,938,468
BSXJoel Greenblatt 2013-12-31 Sold Out -0.01%$11.18 - $12.38
($11.81)
$ 12.597%Sold Out0
BSXLeon Cooperman 2013-09-30 Reduce-0.42%$9.15 - $11.99
($10.83)
$ 12.5916%Reduce -18.19%13,467,416
BSXDodge & Cox 2013-09-30 Reduce-0.25%$9.15 - $11.99
($10.83)
$ 12.5916%Reduce -27.68%59,157,107
BSXVanguard Health Care Fund 2013-09-30 Reduce-0.24%$9.15 - $11.99
($10.83)
$ 12.5916%Reduce -15.74%38,240,700
BSXCharles Brandes 2013-09-30 Sold Out -0.07%$9.15 - $11.99
($10.83)
$ 12.5916%Sold Out0
BSXJoel Greenblatt 2013-09-30 Reduce-0.02%$9.15 - $11.99
($10.83)
$ 12.5916%Reduce -69.22%18,744
BSXCharles Brandes 2013-06-30 Reduce-1.54%$7.09 - $9.64
($8.48)
$ 12.5948%Reduce -96.31%624,088
BSXDodge & Cox 2013-06-30 Reduce-0.14%$7.09 - $9.64
($8.48)
$ 12.5948%Reduce -14.79%81,801,130
BSXJoel Greenblatt 2013-06-30 Reduce-0.03%$7.09 - $9.64
($8.48)
$ 12.5948%Reduce -51.28%60,894
BSXLeon Cooperman 2013-03-31 Add0.24%$5.73 - $7.81
($7.12)
$ 12.5977%Add 13.43%16,473,300
BSXJoel Greenblatt 2013-03-31 Reduce-0.01%$5.73 - $7.81
($7.12)
$ 12.5977%Reduce -20.11%124,980
BSXRay Dalio 2013-03-31 Sold Out -0.0025%$5.73 - $7.81
($7.12)
$ 12.5977%Sold Out0
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

BSX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
BSX Vanguard Health Care Fund 2014-06-3042,743,2003.231.4+16.19%
BSX Michael Price 2014-06-302,000,0000.153.1
BSX Dodge & Cox 2014-06-3044,872,8183.390.55-0.78%
BSX PRIMECAP Management 2014-06-3048,452,0193.660.68-1.82%
BSX Mario Gabelli 2014-06-301,785,8360.140.12-14.92%
BSX Leon Cooperman 2014-06-306,549,4790.51.1-23.25%
BSX Ray Dalio 2014-06-30000Sold Out
BSX Michael Price 2014-03-312,000,0000.153.3
Premium Most recent portfolio changes are included for Premium Members only!


BSX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Phalen Michael P.EVP & President, MedSurg 2014-08-15Sell11,471$12.580.16view
MARIO ERNESTDirector 2014-08-01Sell10,000$12.580.16view
Pierce David ASVP and President, Endoscopy 2014-07-30Sell157$12.97-2.85view
Phalen Michael P.EVP & President, MedSurg 2014-07-15Sell67,500$13.04-3.37view
MARIO ERNESTDirector 2014-07-01Sell10,000$12.95-2.7view
Phalen Michael P.EVP & President, MedSurg 2014-06-16Sell13,500$13.02-3.23view
MARIO ERNESTDirector 2014-06-02Sell10,000$12.88-2.17view
Phalen Michael P.EVP & President, MedSurg 2014-05-15Sell13,500$12.76-1.25view
MARIO ERNESTDirector 2014-05-01Sell10,000$12.580.16view
Phalen Michael P.EVP & President, MedSurg 2014-04-15Sell13,500$13.25-4.91view

Press Releases about BSX :

    Quarterly/Annual Reports about BSX:

    News about BSX:

    Articles On GuruFocus.com
    Diamond Hill Capital Comments on Boston Scientific Corp Jul 25 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jun 26 2014 
    Diamond Hill Select Fund Commentary – First Quarter 2014 Jun 25 2014 
    Diamond Hill Capital Comments on Boston Scientific Corp Jan 15 2014 
    Vanguard Health Care Fund Selling Update Oct 30 2013 
    Diamond Hill Funds Q3 Market Review and Large-Cap Fund Commentary Oct 29 2013 
    Weekly CFO Sells Highlight: BSX, RKUS, MCRL, LRAD and SWKS Sep 08 2013 
    Charles Brandes Top Second Quarter Portfolio Changes Aug 09 2013 
    comment on BSX May 22 2013 
    BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector May 14 2013 


    More From Other Websites
    Demand for Pacemakers Helps Medtronic Beat Estimates Aug 19 2014
    Boston Scientific and ASAHI INTECC Announce Joint Development and Manufacturing Programs Aug 19 2014
    Cyber Attack Nets 4.5 Million Records From Large Hospital System Aug 18 2014
    Boston Scientific Poised on Core Market Stabilization Aug 14 2014
    BOSTON SCIENTIFIC CORP Financials Aug 13 2014
    Healthcare Avoids Black Hat 2014 Spotlight Aug 10 2014
    SHAREHOLDER ALERT: Investigation on Behalf of Boston Scientific Corporation Investors Announced by... Aug 08 2014
    Shareholder Alert: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Boston Scientific... Aug 07 2014
    SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston... Aug 07 2014
    [$$] Boston Scientific Subpoenaed Over Bridgepoint Medical Aug 06 2014
    BOSTON SCIENTIFIC CORP Files SEC form 10-Q, Quarterly Report Aug 06 2014
    Wall Street Transcript Interview with Mark D. Perrin, the CEO of InVivo Therapeutics Corporation... Aug 01 2014
    Vascular Solutions Announces Settlement of Patent Lawsuit With Boston Scientific Jul 30 2014
    Boston Scientific wins first trial over transvaginal mesh device Jul 30 2014
    Boston Scientific Wins First Vaginal-Mesh Injury Trial Jul 29 2014
    How Will Boston Scientific (BSX) Stock Respond To This Coverage Initiation? Jul 29 2014
    UPDATE: Sterne Agee Initiates Coverage On Boston Scientific Jul 29 2014
    AngioDynamics Q4 Earnings Beat, Revenues Up on Higher Sales Jul 24 2014
    Boston Scientific Tops Q2 Earnings, Revenues; Ups EPS View Jul 24 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide